-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Medpace Hldgs, Lowers Price Target to $313

Benzinga·04/23/2025 12:14:15
Listen to the news
Baird analyst Eric Coldwell maintains Medpace Hldgs (NASDAQ:MEDP) with a Neutral and lowers the price target from $340 to $313.